Star Therapeutics Stock
Star Therapeutics discovers and develops novel antibody therapies to address serious diseases with unmet needs, especially in hematology and immunology. It employs a “pipeline-in-a-product” strategy, whereby a single therapeutic program may target multiple diseases that share underlying biology. Its lead program, VGA039, is a first-in-class antibody for bleeding disorders (initially von Willebrand disease) being developed for monthly subcutaneous dosing.
Sign up for SecondMarket® to view the market and buy or sell Star Therapeutics Stock
Buy + SellSee Star Therapeutics Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into Star Therapeutics Stock Valuation + Share Prices
View real-time Tape D® data on Star Therapeutics stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket trading platform.
Get Started
Star Therapeutics Management Team
-
Board Member
Amrit Nagpal
-
Board Member
Beth Seidenberg
-
Board Member
Carl L. Gordon
-
Board Member
Jason Hafler
-
Board Member
Maha Katabi
-
Board Member
Matthew K. Fust
-
Chief Business and Financial Officer
Scott Robertson
-
Co-Founder, Chief Scientific Officer
Sandip Panicker
-
Executive Chair
Nancy Stagliano
-
Founder, CEO, Board Member
Adam Rosenthal
Star Therapeutics Major Investors
-
Catalio Capital Management
-
OrbiMed
-
New Leaf Venture Partners
-
Sanofi Ventures
-
GordonMD Global Investments
-
Viking Global Investors
-
Blue Owl Capital
-
Janus Henderson
-
RA Capital Management
-
Westlake Village BioPartners
-
Redmile Group
-
Cormorant Asset Management
-
Sofinnova Investments
-
Soleus Capital Management
-
Frazier Life Sciences Management
-
Qatar Investment Authority (QIA)
-
NYBC Ventures
-
Agent Capital
Learn More About Star Therapeutics Stock
Buy Star Therapeutics Stock
01Star Therapeutics stock does not trade on public stock exchanges. Star Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Star Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Sell Star Therapeutics Stock
02Star Therapeutics Stock does not trade on public stock exchanges. In order to sell Star Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Star Therapeutics Stock Price
03Star Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Star Therapeutics share price and other valuable private market data.
Read more about secondary market private company stock prices:
Star Therapeutics Stock Ticker Symbol
04There is no ticker symbol for Star Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Criteria to Sell Star Therapeutics Stock
05Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Star Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Criteria to Buy or Invest in Star Therapeutics Stock
06Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Star Therapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Star Therapeutics Stock Settlement
07Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Star Therapeutics IPO
08Star Therapeutics is a private company and has not had an IPO. There is currently no Star Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Star Therapeutics IPO.
Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.
Sign up for SecondMarket® to view the market and buy or sell Star Therapeutics Stock
Buy + Sell*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.